Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Segment Analysis GLP-1 Receptor Agonist Market Analysis by Drug Based on FMI's GLP-1 receptor agonist market report, demand for exenatide is estimated to lead the drug segment, capturing 24.4% of the market share in 2025
Muir D, Neubauer D, Lim IT, Yachnis AT, Wallace MR
The FDA-approved dose for weight management is 2.4 mg weekly (Wegovy), which is higher than the 0.5-1.0 mg doses used for diabetes management
Interestingly, many of our patients have reported that they have experienced rapid weight loss while on this medication
Benefits of GLP-1 Medications Improved Blood Sugar Control : GLP-1 medications help lower blood glucose levels and improve overall glycemic control in people with type 2 diabetes
US$ 27.23
US$ 21.18
US$ 25.00
US$ 28.78
US$ 26.31
